ST同洲(002052) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for the third quarter was ¥37,784,734.06, a decrease of 32.39% compared to the same period last year[2]. - The net profit attributable to shareholders was -¥31,447,069.32, representing an increase of 4.62% year-on-year[2]. - Total operating revenue for the current period is $110.30 million, a decrease of 53.7% compared to $237.66 million in the previous period[20]. - Operating profit (loss) for the current period is -$56.87 million, an improvement from -$64.91 million in the previous period[21]. - Net profit (loss) for the current period is -$57.46 million, compared to -$64.66 million in the previous period, indicating a reduction in losses[22]. Assets and Liabilities - The total assets at the end of the reporting period were ¥567,762,393.82, down 18.12% from the end of the previous year[2]. - The company's current assets decreased to CNY 267,304,477.47 from CNY 383,117,926.93, indicating a reduction of about 30.3%[16]. - The total liabilities of the company were CNY 393,845,247.69, down from CNY 462,277,555.87, which is a decrease of approximately 14.8%[17]. - The company's equity attributable to shareholders decreased from CNY 231,107,987.15 to CNY 173,948,708.17, a decline of about 24.5%[18]. Cash Flow - The company's cash flow from operating activities showed a net outflow of -¥18,076,656.29, a decrease of 4.64% year-to-date[2]. - Cash flow from operating activities shows a net outflow of -$18.08 million, slightly worse than -$17.28 million in the previous period[25]. - Cash and cash equivalents decreased by 50.15% due to repayment of bank loans[8]. - Cash and cash equivalents at the end of the period stand at $33.76 million, down from $62.73 million at the end of the previous period[25]. Expenses - The company reported a 53.59% decrease in operating income year-to-date, primarily due to a reduction in orders[8]. - The company experienced a 39.27% reduction in selling expenses, correlating with the decrease in operating income[8]. - The company incurred research and development expenses of $26.75 million, a decrease of 15.6% from $31.67 million in the previous period[20]. Shareholder and Regulatory Matters - The company is in the process of a non-public offering of A-shares, which has been approved by the board but still requires shareholder and regulatory approvals, introducing significant uncertainty[12]. - The first major shareholder's shares, totaling 123,107,038 shares (16.50% of total shares), are under judicial freeze until May 24, 2023, with the reason for the freeze still unknown[11]. - The company is actively pursuing the recovery of non-operating funds occupied by its associate and may consider further actions to protect its interests[12]. Other Financial Metrics - The basic earnings per share were -¥0.0422, an increase of 4.52% compared to the same period last year[2]. - The company reported a significant increase in credit impairment losses, amounting to $13.28 million compared to a recovery of -$0.38 million in the previous period[21]. - The company generated $146.26 million in cash from sales, down from $332.98 million in the previous period[23].